Naveris: Funding, Investors & Team (Sep 2026)
Naveris is a biotechnology company based in Waltham, Massachusetts that specializes in providing highly sensitive blood tests for early cancer detection in asymptomatic individuals, monitoring treatment response in patients, and detecting cancer recurrence in remission patients. The company uses 3D biomimetic technology to replicate the complex characteristics of human tissues and tumors, allowing for more efficient establishment of patient tumors ex vivo. This technology facilitates innovative designs for oncology clinical trials and precision medicine, aiming to match the most suitable therapies with individual patients. Naveris was established in 2017.
Naveris has raised $50.9M across 2 funding rounds on record, the most recent an undisclosed round of $17.5M announced in Jul 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Naveris Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Naveris Funding Rounds
Naveris raised $33.4M in a Series A announced in Sep 2022.
1.8 years later, an undisclosed round of $17.5M was announced in Jul 2024.
Naveris Founders and Leadership Team
No contact details are on record for this team yet.
Naveris Funding Compared to Other Biotechnology Startups
Naveris' latest round of $17.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Naveris in Biotechnology and Waltham
Companies Similar to Naveris
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Naveris Funding FAQs
What does Naveris do?
Naveris is a biotechnology company based in Waltham, Massachusetts that specializes in providing highly sensitive blood tests for early cancer detection in asymptomatic individuals, monitoring treatment response in patients, and detecting cancer recurrence in remission patients. The company uses 3D biomimetic technology to replicate the complex characteristics of human tissues and tumors, allowing for more efficient establishment of patient tumors ex vivo. This technology facilitates innovative designs for oncology clinical trials and precision medicine, aiming to match the most suitable therapies with individual patients. Naveris was established in 2017.
How much funding has Naveris raised?
Naveris has raised $50.9M across 2 rounds on record. The most recent is an undisclosed round of $17.5M announced in Jul 2024.
When did Naveris last raise funding?
Naveris' most recent funding round on record is an undisclosed round of $17.5M, announced in Jul 2024.
Who founded Naveris?
FundedIQ lists Philip Haydon (Founder) at Naveris.
Who is the CEO of Naveris?
Piyush Gupta is listed as CEO at Naveris.
Where is Naveris headquartered?
Naveris is based in Waltham, Massachusetts, United States.
How many employees does Naveris have?
Naveris is in the 11-50 employee band.
How does Naveris' funding compare to other Biotechnology startups?
Naveris' latest round of $17.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Naveris Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Naveris is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.